Drug Information

Drug General Information
Drug ID
D0Z0QD
Former ID
DNC007583
Drug Name
LVVYPWT
Drug Type
Small molecular drug
Indication Discovery agent Investigative [538627]
Structure
Download
2D MOL

3D MOL
Formula
C45H64N8O10
InChI
InChI=1S/C45H64N8O10/c1-23(2)19-31(46)39(56)50-37(25(5)6)43(60)51-36(24(3)4)42(59)49-34(20-27-14-16-29(55)17-15-27)44(61)53-18-10-13-35(53)41(58)48-33(40(57)52-38(26(7)54)45(62)63)21-28-22-47-32-12-9-8-11-30(28)32/h8-9,11-12,14-17,22-26,31,33-38,47,54-55H,10,13,18-21,46H2,1-7H3,(H,48,58)(H,49,59)(H,50,56)(H,51,60)(H,52,57)(H,62,63)/t26-,31+,33+,34+,35+,36+,37+,38+/m1/s1
InChIKey
BXIFNVGZIMFBQB-DYDSHOKNSA-N
PubChem Compound ID
3081832
PubChem Substance ID
9471177, 14767381, 36412545, 57309565, 57354886, 74545636, 103526546, 104092490, 111683773, 134344788, 135228698, 135652476, 137263214, 162223886, 163304509, 241033523, 241376175, 249617715, 252156884
Target and Pathway
Target(s) P2X purinoceptor 3 Target Info Inhibitor [528976]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
References
Ref 538627(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1026).
Ref 528976J Med Chem. 2007 Sep 6;50(18):4543-7. Epub 2007 Aug 3.Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.